Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Side Effects of Antibiotic Prophylaxis in Pediatric Neurogenic Bladder
NCT02044965Phase 2Unknown
- Sponsor
- London Health Sciences Centre
- Start
- Jan 2015
- Primary completion
- Dec 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus rhamnosus gr-1 in urinary tract infection (UTI), sponsored by London Health Sciences Centre. Status: unknown.
02
Drugs
lactobacillus rhamnosus gr-1
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02044965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044965.